Saiid Zarrabian

Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA.

Pharmacopeia LLC develops small molecule therapeutics to address significant medical needs. The firm operates as clinical development stage Biopharmaceutical Company which focuses on discovering and developing novel small molecule therapeutics to address medical needs. The company was founded by John J. Baldwin in February 2002 and is headquartered in Cranbury, NJ.

Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA.

Cyntellect, Inc. develops life science technologies. Its products supported key applications to advance life science research, biopharmaceutical production, and stem cell research and drug discovery. The company was founded by Paul R. Billings, Manfred R. Koller and Bernhard O. Palsson in 1997 and was headquartered in San Diego, CA.

Part of Dassault Systèmes SA, SciTegic, Inc. designs, develops, and markets data analysis and mining software for the pharmaceutical and biotechnology sectors. The company is based in San Diego, CA. The company was founded by Mathew A. Hahn. SciTegic was acquired by BIOVIA, Inc., part of Dassault Systèmes SA from April 30, 2014 on September 28, 2004 for $20.95 million.

Part of AbbVie, Inc., Exemplar Pharma LLC is a company that manufactures nasal and inhalation canisters. The company is based in Fall River, MA. Exemplar Pharma was acquired by Allergan, Inc., part of AbbVie, Inc. from June 15, 2015 on April 12, 2013 for $16.10 million.

Part of Genesis Biotechnology Group LLC, BioBlocks, Inc. is a collaborative medicinal chemistry research organization based in San Diego, CA. The company focuses on drug discovery from initial hit through identification of development candidates. BioBlocks provides expertise and joins forces with its clients to discover compounds qualified for advancement to phase two clinical trials. Aided by a results-based lead optimization model, BioBlocks scientists have developed multiple preclinical candidates for its partners. The company's leap-to-lead platform provides an alternative source for high-quality tractable leads with multiple possible optimization pathways. The company was founded in 2002 by Peter Pallai, who has been the CEO since 2002. BioBlocks was acquired by Genesis Drug Discovery & Development LLC on October 07, 2021.

eMolecules, Inc. is a company that was founded in 2005 with the aim of reducing drug discovery timelines by improving the compound search and acquisition process. eMolecules is based in San Diego, CA, and has subsidiaries in the Netherlands and the United States. The company has created a powerful, reliable, and accurate digital chemical search engine that connects chemists to the world's largest readily available chemical space. eMolecules specializes in unique structures with dependable delivery options from a trusted network of hundreds of suppliers. The company has an extensive chemical database combined with industry-leading supply chain management, which enables the delivery of compounds quickly and reliably to chemists, allowing for the completion of more syntheses with more confidence and less time in the lab. The company was founded by Craig James and Klaus Gubernator, and the CEO is Niko Gubernator.